Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly inject ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision ...

Amanda Bynes is using Ozempic to lose weight. She wants to weigh 130 lbs. Ozempic is for diabetes but helps with weight loss. It suppresses appetite. Side effects include 'Ozempic face' and vision ...

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 2 ...

Novo Nordisk's blockbuster weight loss and diabetes drugs Wegovy and Ozempic are once again being linked to unintended side effects. Stream Philadelphia News for free, 24/7, wherever you are with ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists ...

The study looked only at Wegovy, not other GLP-1 drugs like Ozempic or Zepbound, which are not approved for teen weight loss. About 8 million U.S. teens—23% of those ages 12 to 19—live with ...

The condition may affect up to 1 in 10,000 people taking semaglutide, the chemical name for Wegovy and Ozempic, the EMA said. (Reporting by Manas Mishra in Bengaluru; advertisement.